Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia
Background: Anti-PD-1/PD-L1 immunotherapy has achieved impressive responses in multiple types of malignancies in recent years. However, immune-related adverse events (irAEs) occur and limit their continuous clinical use. Among these irAEs, acquired amegakaryocytic thrombocytopenia (AAT) is rare but...
Saved in:
Main Authors: | Xiaofang Tu (Author), Ali Xue (Author), Suye Wu (Author), Mengmeng Jin (Author), Pu Zhao (Author), Hao Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia
by: Amina Anwar, et al.
Published: (2023) -
Transient acquired amegakaryocytic thrombocytopenia associated with Pediatric Hodgkin Lymphoma: A case report
by: Fatima Meraj, et al.
Published: (2021) -
Congenital amegakaryocytic thrombocytopenia- A rare case report
by: Ariba Afeeh, et al.
Published: (2024) -
Congenital Amegakaryocytic Thrombocytopenia: A Brief Review of the Literature
by: Fatma S. Al-Qahtani
Published: (2010) -
Myelodysplastic Syndrome Presenting as Amegakaryocytic Thrombocytopenia in a Collodion Baby
by: Mohammed Al Pakra MD, et al.
Published: (2015)